condition-management 12 min read

Histoplasmosis in Cats — Management Guide

Breed: Cat | Published: July 9, 2026 | Source: allpets.ai

Histoplasmosis is a fungal infection that often causes respiratory and gastrointestinal disease in cats in endemic areas. With appropriate diagnosis, itraconazole therapy, and 6–12+ months of monitoring (urine antigen), many cats can achieve remission.

Quick Overview

What it is: Histoplasmosis is an infection caused by the dimorphic fungus Histoplasma capsulatum. Cats inhale microscopic spores (microconidia) from contaminated soil and organic material; the yeast form then multiplies inside macrophages and can remain localized to the lung or disseminate to other organs (commonly the gastrointestinal tract, lymph nodes, liver, spleen).
Who's at risk: Cats that live or spend time outdoors in endemic regions (classically the Ohio and Mississippi River valleys in North America, and parts of Central/South America), cats with heavy outdoor exposure to bird or bat guano, and immunocompromised cats (FIV/FeLV positive) are at higher risk.
Prognosis: Variable. Cats with limited pulmonary disease or isolated GI disease that receive prompt antifungal therapy (most commonly itraconazole) often do well; disseminated or severe pulmonary disease has a guarded to poor prognosis. Long treatment courses (commonly 6–12 months) and careful monitoring reduce relapse risk.

This guide is for educational purposes. Always consult your veterinarian for diagnosis and treatment.

Pathophysiology — explained simply

When soil or old bat/bird guano containing H. capsulatum is disturbed, the mold form releases tiny infectious spores that become airborne. A cat inhales these spores; the warm body transforms them into the yeast phase. These yeasts are taken up by macrophages (immune cells), where they can survive and multiply. From there they may remain in the lungs or travel in macrophages to lymph nodes, liver, spleen, bone marrow and particularly in cats the gastrointestinal tract. Tissue damage and clinical signs result from fungal proliferation and the host inflammatory response.

Endemic areas and prevalence

Classic endemic regions: Ohio and Mississippi River valleys, parts of the southeastern and central United States. Cases also reported in other regions and internationally (Central/South America, parts of Africa and Asia).
Prevalence in cats: Histoplasmosis is not common overall but is one of the more frequently diagnosed systemic mycoses in cats living in endemic regions. Exact prevalence varies by region and local environmental factors; veterinarians in endemic areas should maintain a high index of suspicion.

Breed-specific risk factors

No strong, consistent breed predisposition has been documented for histoplasmosis in cats. Risk correlates mainly with environmental exposure (outdoor access, contact with bird/bat roosts) and immune status rather than breed.

Clinical signs and disease forms

Cats may present with a spectrum of disease from mild, localized respiratory infection to severe disseminated disease. Common presentations:

Pulmonary form

- Cough, increased respiratory effort or rate, dyspnea (may be subtle in cats), exercise intolerance - Fever, weight loss, lethargy - Thoracic radiographs may show interstitial or nodular pulmonary patterns

Gastrointestinal (GI) form (common in cats)

- Chronic weight loss, anorexia, vomiting, diarrhea (often intermittently), melena or hematochezia - Palpable thickened intestines or abdominal masses on exam; ultrasound may show intestinal wall thickening or mesenteric lymphadenopathy

Disseminated/systemic disease

- Fever of unknown origin, generalized lymphadenopathy, hepatosplenomegaly, anemia, thrombocytopenia - Cutaneous lesions, ocular involvement, bone marrow suppression

Disease staging/grade (practical clinical approach)

Mild: Localized disease, minimal systemic signs, stable organ function
Moderate: Multifocal disease or moderate systemic signs (weight loss, persistent fever), some organ dysfunction
Severe: Respiratory distress, marked organ dysfunction (hepatic/renal failure, bone marrow suppression), or life-threatening disseminated infection

Diagnostic approach

A stepwise diagnostic strategy improves speed and accuracy while minimizing risk.

Clinical suspicion and baseline tests

- CBC, serum chemistry (look for anemia, hypoalbuminemia, elevated liver enzymes), urinalysis - Thoracic radiographs for respiratory signs; abdominal ultrasound when GI signs or systemic illness present

Cytology and histopathology (direct visualization)

- Fine-needle aspirates (FNA) of lymph nodes, liver, spleen, or masses; impression smears of intestinal biopsy or skin lesions - Cytology may show small (2–4 µm) intracellular yeasts within macrophages—this finding is highly suggestive - Special stains (GMS, PAS) on cytology or histopathology improve sensitivity - Definitive identification on tissue biopsy (histopathology with special stains) is helpful when cytology is inconclusive

Antigen testing (recommended)

- Urine Histoplasma antigen enzyme immunoassay (EIA) is a sensitive test in cats and dogs and useful for diagnosis and monitoring treatment response. Urine is typically the preferred sample and antigen becomes negative with successful therapy in many cases. - Serum antigen testing can be done but urine is generally more sensitive. - Be aware of cross-reactivity with other endemic fungi (e.g., Blastomyces) — results must be interpreted with clinical context.

Culture and PCR

- Fungal culture is definitive but is slow and requires biosafety precautions (risk to lab personnel) and thus is less commonly used for initial management. - PCR testing is available in some labs and can be helpful but varies by laboratory validation.

Specialist referral

- Consider referral to a veterinary internal medicine or infectious disease specialist when diagnosis is unclear, disease is severe, or advanced diagnostics (endoscopy/biopsy, therapeutic decisions) are required.

Treatment options

Choice of therapy depends on severity, organ involvement, and the cat’s overall condition.

Medical therapy (first-line for most cases)

Itraconazole (azole antifungal)

- Typical dosing for cats: 5–10 mg/kg PO once daily (some clinicians use 5 mg/kg PO q12h; total daily dose generally 5–10 mg/kg). Use lowest effective dose to minimize adverse effects. - Use the oral solution (better absorption) when possible; give with food to improve absorption when using capsules. - Duration: minimum of 4–6 months in mild cases, but most clinicians treat at least 6 months and continue until clinical remission and urine antigen is negative for at least 1–2 months. For many cats total duration is 6–12 months. - Monitoring: baseline and periodic liver enzymes (ALT/AST) every 2–4 weeks initially, then every 2–3 months. Consider therapeutic drug monitoring (trough serum itraconazole concentration) after 2–4 weeks if available — a commonly recommended target trough is ≥1 µg/mL, though targets vary by lab and disease. - Adverse effects: hepatic enzyme elevation, anorexia, vomiting, diarrhea, cutaneous signs. Stop or adjust dose if significant hepatopathy occurs.

Fluconazole

- Alternative for CNS disease (better CSF penetration) or when cost/availability limit itraconazole. Typical dose 50–100 mg/cat PO once daily or 5–10 mg/kg PO q12–24h depending on weight and severity. Fluconazole is less effective than itraconazole for some systemic mycoses and may be associated with higher relapse rates for histoplasmosis.

Amphotericin B (severe or life-threatening disease)

- Indicated for rapidly progressive or life-threatening histoplasmosis, or when azole therapy fails. Because conventional amphotericin B deoxycholate is nephrotoxic, lipid formulations (liposomal amphotericin B) are preferred when available. - Typical dosing (lipid formulation): 1–3 mg/kg IV every 24–48 hours until clinical improvement, with close monitoring of renal function; cumulative dosing strategies are used. Dosing and monitoring should be guided by a specialist and performed in hospital.

Surgical therapy

Rarely required. Biopsy or resection of obstructive intestinal masses may be necessary in cases with severe localized GI lesions causing obstruction or bleeding; surgical decisions are individualized.

Supportive care

Fluid therapy, nutritional support, antiemetics, gastroprotectants, oxygen therapy for respiratory compromise, blood products for severe anemia if needed.

Monitoring and follow-up

Clinical monitoring: assess weight, appetite, energy, respiratory signs, and GI signs frequently (initially every 1–2 weeks, then monthly once stable).
Laboratory monitoring:

- CBC/chemistry every 2–4 weeks early in therapy to detect hepatotoxicity and bone marrow effects, then every 2–3 months. - Urine antigen testing: recommended every 1–3 months to document decreasing antigen levels. Many clinicians continue therapy until urine antigen is negative on at least two consecutive tests spaced 1 month apart; some require a longer negative interval before stopping (e.g., 1–2 months with no clinical signs). - Thoracic radiographs/abdominal ultrasound as clinically indicated to document resolution of lesions.

Monitoring for relapse: after stopping therapy, recheck urine antigen and clinical exam at 1 month, 3 months, and 6 months. Relapses are more likely when therapy is shortened, when antigen remains positive at the time of stopping, or when the cat is immunocompromised.

Treatment duration and relapse risk

Minimum effective length: commonly 4–6 months for mild disease, but most cats are treated 6–12 months. The safest strategy is to continue treatment until clinical resolution and urine antigen negativity for a sustained period.
Relapse: reported in a minority of cases. The best predictor of relapse is stopping therapy while antigen remains positive or persistent immunosuppression (FIV/FeLV). If relapse occurs, re-initiation of azole therapy (often itraconazole) is indicated; amphotericin B may be needed for severe relapse.

Prognosis and quality-of-life considerations

Prognosis depends on disease severity and organ involvement. Cats with mild to moderate disease that respond to itraconazole often return to a good quality of life. Cats with severe pulmonary compromise, marked hypoalbuminemia, or significant organ failure have a guarded prognosis.
Many cats tolerate long-term itraconazole well with monitoring; owners should be counseled about the need for prolonged therapy and periodic bloodwork.

Living with histoplasmosis — practical daily tips

Administering medications: give itraconazole with a small meal to improve absorption. If using oral solution vs capsule, follow your veterinarian’s instructions — the solution is typically better absorbed in cats.
Avoid abrupt discontinuation of antifungal therapy even if the cat seems well; discuss planned stop criteria (clinical remission + urine antigen negativity) with your vet.
Isolation and transmission: histoplasmosis is not commonly transmitted directly from cats to humans. The main risk to people, especially immunocompromised owners, is exposure to environmental sources (soil, guano). Normal hygiene (handwashing after handling litter, minimizing aerosolization of contaminated material) is prudent.
Environmental control: avoid letting your cat dig in or play around old chicken coops, caves, or areas with heavy bird/bat droppings. Remediation of contaminated sites is best handled by public health/environmental professionals.

When to See Your Vet Urgently

Seek immediate veterinary care if your cat has:

Severe difficulty breathing, open-mouth breathing, or collapse
Persistent vomiting or diarrhea causing dehydration
Seizures, severe neurologic signs, or sudden change in behavior
Jaundice (yellow gums or eyes), decreased urine production or bloody urine
Marked weakness, inability to eat, or rapid deterioration despite treatment

Key takeaways

Histoplasmosis should be suspected in cats from endemic areas with respiratory or GI disease, weight loss, and systemic signs.
Diagnosis is most rapid with cytology/histopathology and is greatly supported by urine Histoplasma antigen testing.
Itraconazole is the most commonly used first-line antifungal; typical total daily dose is 5–10 mg/kg PO (once daily or divided). Treatment usually continues for 6–12 months and until urine antigen is negative.
Monitor CBC and liver enzymes periodically; use urine antigen testing to guide therapy duration and detect relapse.

Sources and further reading

Merck Veterinary Manual — Histoplasmosis in Animals: https://www.merckvetmanual.com/respiratory-system/fungal-diseases-of-the-respiratory-system/histoplasmosis
Centers for Disease Control and Prevention (CDC) — Histoplasmosis: https://www.cdc.gov/fungal/diseases/histoplasmosis/index.html
Veterinary internal medicine and infectious disease texts and ACVIM resources on systemic mycoses (consult your veterinarian for specialist referral information).

This guide is for educational purposes. Always consult your veterinarian for diagnosis and treatment.

Frequently Asked Questions

How long will my cat need to be on itraconazole?

Most cats require at least 6 months of therapy; many are treated 6–12 months. Treatment should continue until clinical signs have resolved and urine Histoplasma antigen is negative on repeat testing (often two consecutive negatives). Your veterinarian will tailor duration based on response and monitoring results.

Is histoplasmosis contagious to my family?

Direct transmission from cats to people is not typical. The usual source of human infection is environmental (inhalation of spores from soil or guano). Immunocompromised people should practice caution and good hygiene when handling litter or cleaning areas where large amounts of droppings are present.

What tests are most useful to confirm histoplasmosis?

Cytology or histopathology showing intracellular yeasts combined with a positive urine Histoplasma antigen test provides strong evidence. Culture and PCR can be used but have limitations; culture is slow and requires biosafety precautions.

What if my cat doesn't improve on itraconazole?

If there is no improvement after an appropriate trial, or if disease is severe, your veterinarian may add or switch to amphotericin B (usually a lipid formulation) and consult a specialist. Re-evaluation (imaging, repeat antigen testing, biopsy) is often needed to confirm diagnosis and assess response.

References & Citations

Parts of this article reference data from Merck Veterinary Manual.

Tags: cat-healthfungal-infectionhistoplasmosisveterinary-internal-medicine